Pharma/BioTech Update: Biogen Idec’s Hemophilia Drug Price to Remain on Par
An article released today by FiercePharma stated that Biogen Idec’s new hemophilia B drug, Alprolix, will be priced similarly to older and…
An article released today by FiercePharma stated that Biogen Idec’s new hemophilia B drug, Alprolix, will be priced similarly to older and…
Raritan Valley Community College recently sent out a press release announcing their third annual Hemophilia Bleeding Disorders Awareness Walk on…
A recent article written by Michael Calia at NASDAQ shows promise for Biogen Idec’s up and coming hemophilia A (factor VIII deficiency)…
An article from TheSpec.com recently touched on a hard subject that has affected the bleeding community for over 30 years. The…
On this episode of “The Missing Factor”, Drew sits down with Greg Price and John DeWolf, who are both hemophiliacs,…
WeBleed is pleased to share a mother’s blog titled “2 Brothers with Hemophilia: The Journey of 2 Brothers with Severe…
Understanding the Affordable Healthcare Act (ACA) can be a challenge. With the introduction of the ACA a few years ago…
Kashmir, a country located in the southwestern region of India released an all too familiar story yesterday via Greater Kashmir….
News out of Korea today via The Korea Times is breaking a story stating that Bayer has decided to stop importing…
Who: Hemophilia Federation of America (HFA) What: HFA Annual Symposium Where: Tampa, Florida When: March 27 – 29, 2014 Click…